Aam Aadmi Party (AAP) MP Sanjay Singh on Thursday fired back at BJP MLA Ravinder Singh Negi's demand to shut down meat shops in Delhi during Navratri. He also questioned why KFC shops and ...
Studio Ghibli-inspired images have taken social media by storm, with many, including Bollywood stars like Sanjay Dutt, Rakul Preet Singh, and Arjun Kapoor, joining the trend. Fans can’t get ...
AbbVie (ABBV) rebounds after losses, gaining ~% as analysts stay bullish. Discover why its obesity drug deal boosts long-term ...
The much-anticipated trailer of The Bhootnii, starring Sanjay Dutt, Mouni Roy, Sunny Singh, Palak Tiwari, Aasif Khan, and Beyounick, is finally out! Blending horror, action, and comedy the film ...
Bollywood actor Sanjay Dutt on Saturday (March 29) confirmed working with Salman Khan on a new action film. Recently, Salman at a press meet disclosed that he will feature in a big, ‘rustic ...
I'll start by comparing the revenue growth rates of AbbVie and Sanofi, then move on to discuss how often these two leaders in the autoimmune disease treatment market beat Wall Street analysts ...
Sanjay Raut demands special protection for comedian Kunal Kamra, who faces multiple legal cases over remarks about Maharashtra deputy CM Eknath Shinde. He compares Kamra's situation to that of ...
Salman Khan, who is preparing for his grand return to theatres with Sikandar, has confirmed an exciting new project with his close friend and Bollywood actor Sanjay Dutt. During the promotions of ...
Sanjay Dutt was born in Bombay. He is the son of finest actors Sunil Dutt and Nargis Dutt. He made his acting debut in 1981 with Rocky. He gave amazing performances in films like Saajan, Sadak ...
NDP Leader Jagmeet Singh says his party would bar corporations from buying existing affordable rental buildings. The NDP said the policy pledge applies to financialized landlords, a distinct ...
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared for folate receptor-alpha (FRα) positive, platinum-resistant ...
AbbVie has joined the ranks of pharma groups trying to develop weight-loss drugs, licensing a long-acting amylin analogue from Denmark's Gubra in a deal valued at more than $2.2 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results